Stocks and Investing
Stocks and Investing
Tue, December 13, 2016
[ 06:45 PM ] - United States, WOPRAI
[ 06:45 PM ] - United States, WOPRAI
[ 06:45 PM ] - United States, WOPRAI
[ 11:45 AM ] - United States, WOPRAI
[ 09:46 AM ] - United States, WOPRAI
[ 09:46 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Madhu Kumar Downgraded (ABUS) to Hold and Decreased Target to $3 on, Dec 13th, 2016
Madhu Kumar of Chardan Capital, Downgraded "Arbutus Biopharma Corporation" (ABUS) to Hold and Decreased Target from $4 to $3 on, Dec 13th, 2016.
Madhu, nor any peers, have made any analyst calls on ABUS in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources